Jeffrey L. Wade

2021

In 2021, Jeffrey L. Wade earned a total compensation of $1.7M as President and Chief Financial Officer at Lexicon Pharmaceuticals, a 1% increase compared to previous year.

Compensation breakdown

Bonus$227,250
Option Awards$652,559
Salary$476,319
Stock Awards$280,981
Other$14,574
Total$1,651,683

Wade received $652.6K in option awards, accounting for 40% of the total pay in 2021.

Wade also received $227.3K in bonus, $476.3K in salary, $281K in stock awards and $14.6K in other compensation.

Rankings

In 2021, Jeffrey L. Wade's compensation ranked 6,829th out of 12,415 executives tracked by ExecPay. In other words, Wade earned more than 45.0% of executives.

ClassificationRankingPercentile
All
6,829
out of 12,415
45th
Division
Manufacturing
2,972
out of 5,505
46th
Major group
Chemicals And Allied Products
1,317
out of 2,375
45th
Industry group
Drugs
1,174
out of 2,096
44th
Industry
Pharmaceutical Preparations
856
out of 1,546
45th

Pay ratio

Jeffrey L. Wade's Pay$1,651,683
Median Employee's Pay$234,672
Pay Ratio

7

to 1

In 2021, the annual total compensation of Jeffrey L. Wade was $1,651,683.

The annual total compensation of the median employee at Lexicon Pharmaceuticals was $234,672.

The ratio of Jeffrey L. Wade's pay to the pay of median employee was therefore 7 to one.

Source: SEC filing on April 8, 2022.

Wade's colleagues

We found four more compensation records of executives who worked with Jeffrey L. Wade at Lexicon Pharmaceuticals in 2021.

2021

Lonnel Coats

Lexicon Pharmaceuticals

Chief Executive Officer

2021

Alan Main

Lexicon Pharmaceuticals

Executive Vice President, Innovation and Chemical Sciences

2021

Brian Crum

Lexicon Pharmaceuticals

General Counsel

2021

Craig Granowitz

Lexicon Pharmaceuticals

Chief Medical Officer

News

You may also like